Anti-TNFRSF5/CD40 Antibody (Dacetuzumab)
Catalog No.
F1055
Anti-TNFRSF5/CD40 Antibody (Dacetuzumab)
Featured Products
Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells through immune effector actions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40)) is indicated for multiple myeloma research.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
880486-59-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RG-3636, SGN 14, SGN-14
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P25942
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human TNFRSF5 / CD40 His at 2 ug/mL can bind Anti-TNFRSF5/CD40 Antibody (Dacetuzumab)
TNFRSF5 / CD40
Please avoid freeze-thaw cycles.